Concepedia

Dongmei Li

DL

Statistics

Publications

4

Citations

199

H-Index

4

Active since

2016

Affiliations

State Key Laboratory of Medicinal Chemical Biology(Current)

Tianjin International Joint Academy of Biomedicine

Nankai University

Dongmei Li is an author at State Key Laboratory of Medicinal Chemical Biology specializing in virtual screening, biomolecular engineering, and molecular docking.

ORCID

Top concepts

Publications per year

2016–2022

4

Publications

4

Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting Mpro and Ameliorates Pulmonary Inflammation

Ting Xiao, Mengqi Cui, Caijuan Zheng et al. · Frontiers in Pharmacology · 2021 · 82 citations · Full text

Discovery of Novel Hepatitis C Virus NS5B Polymerase Inhibitors by Combining Random Forest, Multiple e-Pharmacophore Modeling and Docking

Yu Wei, Jinlong Li, Jie Qing et al. · PLoS ONE · 2016 · 56 citations · Full text

, , +20

Network Pharmacology–Based Identification of Key Mechanisms of Xihuang Pill in the Treatment of Triple-Negative Breast Cancer Stem Cells

Yuzhu Zhang, Jiayao Yang, Ruixian Wu et al. · Frontiers in Pharmacology · 2021 · 31 citations · Full text

The full activation mechanism of the adenosine A <sub>1</sub> receptor revealed by GaMD and Su-GaMD simulations

Yang Li, Jixue Sun, Dongmei Li et al. · Proceedings of the National Academy of Sciences · 2022 · 30 citations · Full text

1–4 of 4